Jane Cooke Wright
At Harlem Hospital in the 1950s she showed methotrexate could shrink breast and skin cancers, tested drugs on patients' own tumour cells, and in 1964 was the only woman among the seven founders of ASCO.
Jane Cooke Wright (1919-2013) joined her father Louis Wright's Cancer Research Foundation at Harlem Hospital in 1949 and became its director in 1952. At a time when chemotherapy was regarded as a last resort for leukaemia, she showed that methotrexate produced responses in breast cancer, mycosis fungoides and other solid tumours, and pioneered testing candidate drugs against a patient's own tumour cells in culture to guide treatment, an idea now returning as functional precision medicine. She developed regional perfusion of chemotherapy for hard-to-reach tumours. In 1964 she was the only woman and the only African American among the seven founders of the American Society of Clinical Oncology, and in 1967 became associate dean of New York Medical College, then the highest post held by a Black woman at a US medical school. She served on the President's Commission on Heart Disease, Cancer and Stroke.
Pages like this
not linked directly; found by shared links- PersonDonald Pinkel
Shares Methotrexate, Cancer health disparities and equity, Cytotoxic chemotherapy and the tags hero, pioneer.
- PersonEmil J Freireich
Shares Methotrexate, Cytotoxic chemotherapy and the tags hero, pioneer.
- PersonSidney Farber
Shares Methotrexate, Cytotoxic chemotherapy and the tags hero, pioneer.
- PersonGertrude Elion
Shares Cytotoxic chemotherapy and the tags hero, pioneer.
- PersonEmil "Tom" Frei III
Shares Cytotoxic chemotherapy and the tags hero, pioneer.
- PersonBernard Fisher
Shares the tags hero, pioneer.
- PersonBrian Druker
Shares the tags hero, pioneer.
- PersonHarald zur Hausen
Shares the tags hero, pioneer.